Evaluate the Efficacy of Xuebijing Injection in Acute Exacerbations of COPD

Exclusion Criteria

• •1. Pregnant women, lactating women；
• •2. Be allergic to Xuebijing；
• •3. Acute exacerbation of COPD onset of more than 72 hours；
• •4. AECOPD with severe hypoxemia：oxygenation index \<150 or received Endotracheal intubation invasive mechanical ventilation；
• •5. Participation in another experimental protocol within 30 days of study entry
• •6. Primary diseases：Asthma，Cystic fibrosis，Lung cancer，Tuberculosis，Pulmonary sarcoidosis，Pulmonary interstitial fibrosis，Malignant neoplasms，Blood system diseases，HIV；
• •7. Complications：Pulmonary embolism，shock，DIC，Unstable cardiovascular disease，Upper gastrointestinal bleeding，pneumothorax，Severe liver and kidney dysfunction；
• •8. Mental incompetence or active psychiatric illness
• •9. used the following drugs within 72 hours days of study entry：Ulinastatin，Tanreqing， Reduning，Qingkailing；
• •10. The investigator judged that the subject could not be completed or should not participate in the trial：Hemodialysis more than 1 mouth，Organ transplant patients with potential medical dispute.